Results for Development Institute, Washington, DC, USA.
National Center for Global Health and Medicine, Bureau of International Health Cooperation, Tokyo, Japan.
BMC Public Health. 2023 Jul 31;23(1):1454. doi: 10.1186/s12889-023-16383-3.
Anaemia is a reduction in haemoglobin concentration below a threshold, resulting from various factors including severe blood loss during and after childbirth. Symptoms of anaemia include fatigue and weakness, among others, affecting health and quality of life. Anaemic pregnant women have an increased risk of premature delivery, a low-birthweight infant, and postpartum depression. They are also more likely to have anaemia in the postpartum period which can lead to an ongoing condition and affect subsequent pregnancies. In 2019 nearly 37% of pregnant women globally had anaemia, and estimates suggest that 50-80% of postpartum women in low- and middle-income countries have anaemia, but currently there is no standard measurement or classification for postpartum anaemia.
A rapid landscape review was conducted to identify and characterize postpartum anaemia measurement searching references within three published systematic reviews of anaemia, including studies published between 2012 and 2021. We then conducted a new search for relevant literature from February 2021 to April 2022 in EMBASE and MEDLINE using a similar search strategy as used in the published reviews.
In total, we identified 53 relevant studies. The timing of haemoglobin measurement ranged from within the immediate postpartum period to over 6 weeks. The thresholds used to diagnose anaemia in postpartum women varied considerably, with < 120, < 110, < 100 and < 80 g/L the most frequently reported. Other laboratory results frequently reported included ferritin and transferrin receptor. Clinical outcomes reported in 32 out of 53 studies included postpartum depression, quality of life, and fatigue. Haemoglobin measurements were performed in a laboratory, although it is unclear from the studies if venous samples and automatic analysers were used in all cases.
This review demonstrates the need for improving postpartum anaemia measurement given the variability observed in published measures. With the high prevalence of anaemia, the relatively simple treatment for non-severe cases of iron deficiency anaemia, and its importance to public health with multi-generational effects, it is crucial to develop common measures for women in the postpartum period and promote rapid uptake and reporting.
贫血是血红蛋白浓度低于阈值的一种表现,其由各种因素导致,包括分娩中和分娩后的严重失血。贫血的症状包括疲劳和虚弱等,会影响健康和生活质量。患有贫血的孕妇早产、低体重儿和产后抑郁症的风险增加。她们在产后也更容易出现贫血,这可能导致持续存在的情况,并影响后续怀孕。2019 年,全球近 37%的孕妇患有贫血,据估计,中低收入国家 50-80%的产后妇女患有贫血,但目前产后贫血没有标准的测量或分类方法。
我们进行了快速的文献综述,以确定和描述产后贫血的测量方法,在三篇关于贫血的已发表系统综述中搜索参考文献,包括 2012 年至 2021 年期间发表的研究。然后,我们在 EMBASE 和 MEDLINE 中使用与已发表综述相似的搜索策略,从 2021 年 2 月至 2022 年 4 月进行了新的相关文献搜索。
共确定了 53 项相关研究。血红蛋白测量的时间范围从产后立即到 6 周以上。用于诊断产后妇女贫血的阈值差异很大,<120、<110、<100 和<80g/L 是最常报道的。其他经常报告的实验室结果包括铁蛋白和转铁蛋白受体。在 53 项研究中的 32 项中报告了临床结局,包括产后抑郁、生活质量和疲劳。血红蛋白测量是在实验室进行的,尽管从研究中不清楚是否在所有情况下都使用了静脉样本和自动分析仪。
鉴于发表的测量方法存在差异,本综述表明需要改进产后贫血的测量方法。鉴于贫血的高患病率、非严重缺铁性贫血的相对简单治疗方法,以及其对公共卫生的重要性及其对多代人的影响,为产后妇女制定共同的测量方法并促进快速采用和报告至关重要。